ClassID:

90491

C07B2200/07 - page 3 - CPC Classification

Classification description:

Indexing scheme relating to specific properties of organic compounds Optical isomers

Recent Application in this class:
#601
20180327349
2018-11-15

Processes for the preparation of diastereomerically and enantiomerically enriched oxazolines

#602
20180327343
2018-11-15

Compositions and methods for preparing β,γ-unsaturated acids

#603
20180326101
2018-11-15

COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TARGETED DRUG DELIVERY

#604
20180319773
2018-11-08

Triazole agonists of the APJ receptor

#605
20180312474
2018-11-01

KDM1A inhibitors for the treatment of disease

#606
20180312463
2018-11-01

Synthesis of Cyclohexane Carboxamide Derivatives Useful as Sensates in Consumer Products

#607
20180312454
2018-11-01

Process for the preparation of deuterated ethanol from D2

#608
20180312450
2018-11-01

Process for the preparation of deuterated ethanol from DO

#609
20180305308
2018-10-25

Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt

#610
20180297990
2018-10-18

Dopamine D3 receptor antagonists having a morpholine moiety

#611
20180297982
2018-10-18

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

#612
20180297942
2018-10-18

Polyamine sulfonamides and uses thereof

#613
20180297935
2018-10-18

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#614
20180290996
2018-10-11

Method for preparing thienyl alanine having optical activity

#615
20180290990
2018-10-11

DESFERRITHIOCIN POLYETHER ANALOGUES

#616
20180290976
2018-10-11

LSD1 inhibitors and uses thereof

#617
20180290971
2018-10-11

Deuterated 3-methanesulfonylpropionitrile

#618
20180282344
2018-10-04

Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof

#619
20180282266
2018-10-04

(S)-CSA salt of S-ketamine, (R)-CSA salt of S-ketamine and processes for the preparation of S-ketamine

#620
20180280317
2018-10-04

METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL

#621
20180273565
2018-09-27

Method for producing ruthenium complex

#622
20180273468
2018-09-27

Process for the preparation of (1S,2R)-Milnacipran

#623
20180273441
2018-09-27

Methods for low temperature fluorine-18 radiolabeling of biomolecules

#624
20180265513
2018-09-20

Process for the preparation of dipeptidyl peptidase-4 (DPP-4) enzyme inhibitor

#625
20180265467
2018-09-20

PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS

#626
20180265459
2018-09-20

Disubstituted amino acids and methods of preparation and use thereof

#627
20180265442
2018-09-20

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#628
20180258116
2018-09-13

(R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation

#629
20180258031
2018-09-13

Stereoselective process

#630
20180250291
2018-09-06

Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use

#631
20180244701
2018-08-30

Phosphoramidate compound and preparation method and crystal thereof

#632
20180244695
2018-08-30

Quinoline derivative, and pharmaceutical composition, preparation method and use thereof

#633
20180244670
2018-08-30

Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient

#634
20180244623
2018-08-30

N-methyl-D-aspartate receptor (NMDAR) potentiators, pharmaceutical compositions, and uses related thereto

#635
20180244598
2018-08-30

Method for synthesizing optically active carbonyl compounds

#636
20180237457
2018-08-23

Imidazopyridazine and imidazothiadiazole compounds

#637
20180237415
2018-08-23

Amide derivatives having multimodal activity against pain

#638
20180237381
2018-08-23

Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity

#639
20180237377
2018-08-23

Process for the Synthesis of Melphalan and the Hydrochloride Salt

#640
20180230159
2018-08-16

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#641
20180230112
2018-08-16

Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols

#642
20180230097
2018-08-16

Process for preparation of apremilast and novel polymorphs thereof

#643
20180230092
2018-08-16

NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION

#644
20180230082
2018-08-16

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

#645
20180222894
2018-08-09

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

#646
20180222860
2018-08-09

Substituted indoles as modulators of ROR-gamma

#647
20180222845
2018-08-09

LEVALBUTEROL SALT

#648
20180222840
2018-08-09

Method for the preparation of (S)-2-acetyloxypropionic acid and derivatives thereof

#649
20180217113
2018-08-02

Method for analyzing enantiomer

#650
20180215702
2018-08-02

Enamide process

#651
20180215700
2018-08-02

Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein

#652
20180214853
2018-08-02

Oxidation catalysts

#653
20180209985
2018-07-26

Reagents for quantitative mass spectrometry

#654
20180208552
2018-07-26

Urea derivative or pharmacologically acceptable salt thereof

#655
20180208542
2018-07-26

Method for preparing selegiline base

#656
20180208540
2018-07-26

Fruity odorant

#657
20180207625
2018-07-26

Enantiomerically enriched, polycrystalline molecular sieves

#658
20180201623
2018-07-19

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

#659
20180201558
2018-07-19

Process for production of D-Sorbitol

#660
20180194777
2018-07-12

Diaryl macrocycle polymorph

#661
20180194724
2018-07-12

Cyanopyrrolidines as dub inhibitors for the treatment of cancer

#662
20180194721
2018-07-12

Difluoroalkylcyclopropyl amino acids and esters, and syntheses thereof

#663
20180187217
2018-07-05

Carbonyl reductase oligomers and their application in synthesis of chiral alcohols

#664
20180186803
2018-07-05

Short-acting benzodiazepine salts and their polymorphic forms

#665
20180186743
2018-07-05

Picolinamides as fungicides

#666
20180186725
2018-07-05

Method for the homogeneous catalytic reductive amination of carbonyl compounds

#667
20180179222
2018-06-28

Deuterated thienopiperidine derivatives, manufacturing method, and application thereof

#668
20180179164
2018-06-28

Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anticancer ingredient, pharmaceutical composition, medicinal preparation, method for treating prostate cancer

#669
20180179120
2018-06-28

Atropisomers and methods of altering enantiomeric excess

#670
20180170867
2018-06-21

STEREOSELECTIVE SYNTHESIS OF 9-CIS.13,14-DIHYDRORETINOIC ACID AND ITS ETHYL ESTERS

#671
20180163157
2018-06-14

2-octylcyclopropyl-1-carboxylic acid and the isomers thereof, and uses of same

#672
20180162850
2018-06-14

2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor

#673
20180162805
2018-06-14

Method for preparing citalopram diol intermediate

#674
20180161324
2018-06-14

SHIP1 modulators and methods related thereto

#675
20180155339
2018-06-07

Method for the production of praziquantel

#676
20180155300
2018-06-07

Solid state forms of trisodium valsartan: sacubitril

#677
20180155289
2018-06-07

Mixed disulfide conjugates of thienopyridine compounds and uses thereof

#678
20180148456
2018-05-31

Notch pathway signaling inhibitor compounds

#679
20180140582
2018-05-24

Benzothiazolone compound

#680
20180134660
2018-05-17

Process for the enantiomeric resolution of apremilast intermediates

#681
20180134650
2018-05-17

Enantiospecific process for the preparation of (R) and (S) enantiomers of sex pheromonoes of the long tailed mealy bug

#682
20180127809
2018-05-10

Photoprotective mixtures as imaging reagents in sequencing-by-synthesis

#683
20180127429
2018-05-10

Ethynyl derivatives

#684
20180127368
2018-05-10

Tricyclic sulfones as ROR gamma modulators

#685
20180125823
2018-05-10

Imidazole derivatives

#686
20180118707
2018-05-03

BETA-NAPHTHOISOFLAVONES, COMPOSITIONS CONTAINING, AND USES OF, SAME

#687
20180111956
2018-04-26

Synthesis of desosamines

#688
20180111944
2018-04-26

(R)-pirlindole and its pharmaceutically acceptable salts for use in medicine

#689
20180104242
2018-04-19

4-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredient

#690
20180099919
2018-04-12

Process for the preparation of (1R,3R)- and (1S,3S)-2,2-dihalo-3-(substituted phenyl)cyclopropanecarboxylic acids

#691
20180098994
2018-04-12

Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals

#692
20180098993
2018-04-12

USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN

#693
20180098956
2018-04-12

THERAPEUTIC COMPOSITIONS

#694
20180086722
2018-03-29

Processes for the preparation of pyrimidinylcyclopentane compounds

#695
20180086702
2018-03-29

Indole analogs as 5-oxo-ETE receptor antagonists and method of use thereof

#696
20180079758
2018-03-22

Substituted tetrahydrocarbazole and carbazole carboxamide compounds

#697
20180079741
2018-03-22

PROCESS FOR PRODUCING HETEROCYCLIC COMPOUND

#698
20180079731
2018-03-22

Axially chiral isomers, and preparation methods therefor and pharmaceutical uses thereof

#699
20180079709
2018-03-22

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#700
20180072768
2018-03-15

Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridines

#701
20180072693
2018-03-15

Method for synthesizing a precursor of a single dairy-lactone isomer

#702
20180065919
2018-03-08

Mixtures of chelating agents including an L-enantiomer-rich MGDA, and process for making such mixtures

#703
20180057478
2018-03-01

AMPK-activating heterocyclic compounds and methods for using the same

#704
20180057472
2018-03-01

Derivatives of sobetirome

#705
20180057437
2018-03-01

Method for synthesizing optically active carbonyl compounds

#706
20180050996
2018-02-22

Heterocyclic compound

#707
20180050052
2018-02-22

Neprilysin inhibitors

#708
20180044295
2018-02-15

Compounds for modulating mitochondrial function

#709
20180044285
2018-02-15

METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF OREXIN-2 RECEPTOR ANTAGONISTS

#710
20180044279
2018-02-15

Method for isomerizing bis(aminomethyl) cyclohexane

#711
20180037541
2018-02-08

Picolinamides with fungicidal activity

#712
20180037529
2018-02-08

Myricanol derivatives and uses thereof for treatment of neurodegenerative diseases

#713
20180030045
2018-02-01

Selectively substituted quinoline compounds

#714
20180029976
2018-02-01

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

#715
20180029975
2018-02-01

Synthesis process for chiral cyclopropyl ethynyl tertiary alcohol compound

#716
20180022695
2018-01-25

Glucagon antagonists

#717
20180022690
2018-01-25

Process and intermediates for the preparation of NEP inhibitors

#718
20180009801
2018-01-11

Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors

#719
20180008971
2018-01-11

Method for producing proton pump inhibitor compound having optical activity

#720
20180002338
2018-01-04

Short-acting benzodiazepine salts and their polymorphic forms

#721
20180002247
2018-01-04

METHODS FOR CHIRAL RESOLUTION OF TROLOX

#722
20170369421
2017-12-28

Picolinamides with fungicidal activity

#723
20170369420
2017-12-28

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

#724
20170362166
2017-12-21

β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof

#725
20170362162
2017-12-21

Synthesis of amides and amines from aldehydes or ketones by heterogeneous metal catalysis

#726
20170361310
2017-12-21

Chiral N-substituted allylic amine compounds

#727
20170360730
2017-12-21

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#728
20170360037
2017-12-21

3′-substituted-abscisic acid derivatives

#729
20170349534
2017-12-07

A NOVEL PROCESS FOR CHIRAL RESOLUTION OF HIGHLY PURE (6R)-6-(DIMETHYLAMINO)-4,4-DIPHENYL-HEPTANONE FROM RACEMIC METHADONE HYDROCHLORIDE

#730
20170348257
2017-12-07

Trifluoromethylpropanamide derivatives

#731
20170342027
2017-11-30

Chiral resolution method of N-[4-(1-aminoethyl)-phenyl]-sulfonamide derivatives

#732
20170334834
2017-11-23

Antifibrinolytic compounds

#733
20170334831
2017-11-23

Kinetic resolution of racemic hydroxy ester via asymmetric catalytic hydrogenation and application thereof

#734
20170333374
2017-11-23

S-(carboxymethyl)-cysteine pharmaceutical compound and preparation method and use thereof

#735
20170327473
2017-11-16

Process for the preparation of tetraconazole

#736
20170326115
2017-11-16

Chemical compounds

#737
20170320873
2017-11-09

Method for the production of Praziquantel and precursors thereof

#738
20170313680
2017-11-02

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

#739
20170297990
2017-10-19

Process for producing alcohol analogue

#740
20170291878
2017-10-12

Methods for producing optically active valeric acid derivatives

#741
20170283411
2017-10-05

Optically active α-trifluoromethyl-β-amino acid derivative production method

#742
20170283391
2017-10-05

Chiral separation of Δ-THC, Δ-THC, and related enantiomers using CO-based chromatography

#743
20170283349
2017-10-05

Method and device for producing L-menthol in solid form

#744
20170282169
2017-10-05

ALUMINUM CATALYST

#745
20170281597
2017-10-05

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

#746
20170275303
2017-09-28

Chiral binuclear metal complexes for stereoselective hydrolysis of saccharides and glycosides

#747
20170275240
2017-09-28

Method for preparing chiral gamma-secondary amino alcohol

#748
20170266196
2017-09-21

PROCESS FOR PREPARATION OF OPTICALLY PURE AND OPTIONALLY SUBSTITUTED 2-(1-HYDROXY-ALKYL)-CHROMEN-4-ONE DERIVATIVES AND THEIR USE IN PREPARING PHARMACEUTICALS

#749
20170260189
2017-09-14

Method of preparing AZA-pyridone compounds

#750
20170260119
2017-09-14

Asymmetrical hydrogenation reaction of ketonic acid compound

#751
20170253538
2017-09-07

Enantioselective destruction of chiral molecules

#752
20170247362
2017-08-31

Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same

#753
20170247338
2017-08-31

Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds

#754
20170240494
2017-08-24

Method and device for separating a substance out of a solution

#755
20170233338
2017-08-17

Method for producing astaxanthin from astacin

#756
20170233329
2017-08-17

Process for the preparation of amino alcohol derivatives or salts thereof

#757
20170217921
2017-08-03

COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM

#758
20170217886
2017-08-03

Process for preparation of dexmethylphenidate hydrochloride

#759
20170217884
2017-08-03

Process for preparing cyclic alpha-keto alcohols from cyclic alpha-keto enols

#760
20170216241
2017-08-03

α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof

#761
20170210696
2017-07-27

Process for the preparation of Metaraminol

#762
20170204079
2017-07-20

Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#763
20170204036
2017-07-20

Chiral diamine compounds for the preparation of chiral alcohols and chiral amines

#764
20170197156
2017-07-13

Superficially porous particle (SPP) chiral phases for liquid chromatography

#765
20170190692
2017-07-06

ATRASENTAN MANDELATE SALTS

#766
20170172969
2017-06-22

Methods of sustaining dietary ketosis and its effects on lipid profile

#767
20170158607
2017-06-08

Organocatalytic asymmetric synthesis of antidepressants

#768
20170145024
2017-05-25

Process for obtaining optically active pirlindole enantiomers and salts thereof

#769
20170145015
2017-05-25

(R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE

#770
20170145005
2017-05-25

KINASE INHIBITOR

#771
20170137374
2017-05-18

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

#772
20170129872
2017-05-11

Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines

#773
20170129852
2017-05-11

Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethylamine

#774
20170121341
2017-05-04

Optically active 2-hydroxy tetrahydrothienopyridine derivatives, preparation method and use in manufacture of medicament thereof

#775
20170121261
2017-05-04

DIGLYCIDIC ETHER DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE

#776
20170114050
2017-04-27

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

#777
20170114006
2017-04-27

Substituted biaryl alkyl amides

#778
20170107193
2017-04-20

CRYSTALLINE LENALIDOMIDE PROCESS

#779
20170107175
2017-04-20

Crystalline diacylhydrazine and the use thereof

#780
20170088540
2017-03-30

Antifungal compound process

#781
20170088503
2017-03-30

Compound, and flavor composition and/or fragrance composition containing same

#782
20170081305
2017-03-23

Process for producing heterocyclic compound

#783
20170073351
2017-03-16

ENANTIOMERS OF SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

#784
20170071909
2017-03-16

γ-aminobutyric acid (GABA) analogues for the treatment of pain and other disorders

#785
20170066728
2017-03-09

PROCESS FOR THE PREPARATION OF STABLE CRYSTALLINE FORM-I OF LINEZOLID, SUBSTANTIALLY FREE OF RESIDUAL SOLVENT

#786
20170066714
2017-03-09

Disubstituted amino acids and methods of preparation and use thereof

#787
20170057916
2017-03-02

Forms of apremilast and the process of making the same

#788
20170057909
2017-03-02

Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof

#789
20170052131
2017-02-23

Chiral metal complex and use thereof for analyzing chirality of charged compound by H NMR spectroscopy

#790
20170051003
2017-02-23

Reagent-controlled stereoselective glycosylation

#791
20170050926
2017-02-23

Benzamide compounds and related methods of use

#792
20170050923
2017-02-23

T-Butylketone binaphthol derivative and method of preparing the same

#793
20170050921
2017-02-23

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

#794
20170049780
2017-02-23

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

#795
20170044155
2017-02-16

Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors

#796
20170044131
2017-02-16

Methods for preparing triazole agonists of the APJ receptor

#797
20170044092
2017-02-16

Cannabidiol quinone derivatives

#798
20170042897
2017-02-16

Intermediates for preparing triazole agonists of the APJ receptor

#799
20170042892
2017-02-16

Histone deacetylase inhibitors and compositions and methods of use thereof

#800
20170042872
2017-02-16

Triazole agonists of the APJ receptor

#801
20170042871
2017-02-16

Triazole agonists of the APJ receptor

#802
20170037063
2017-02-09

Controlling the isomerization rate of Azo-BF2 switches using aggregation

#803
20170037026
2017-02-09

Triazole agonists of the APJ receptor

#804
20170036992
2017-02-09

Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof

#805
20170035744
2017-02-09

Intermediates for preparing triazole agonists of the APJ receptor

#806
20170029402
2017-02-02

PROCESS FOR THE PREPARATION OF CHIRAL 8-(3-AMINOPIPERIDIN-1-YL)-XANTHINES

#807
20170028386
2017-02-02

Processes for the manufacturing of oxidation catalysts

#808
20170020904
2017-01-26

Neprilysin inhibitors

#809
20170015680
2017-01-19

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

#810
20170015620
2017-01-19

Process for the preparation of exametazime

#811
20170008917
2017-01-12

Method for preparing racemic or optically active α-glycerophosphorylcholine

#812
20170008863
2017-01-12

Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions

#813
20170008832
2017-01-12

Two-step process for preparing 3-substituted phenylalkylamines

#814
20170008820
2017-01-12

Method for producing optically active carboxylic acid ester

#815
20170001963
2017-01-05

N-substituted imidazole carboxylic ester chiral compound containing an ether side chain, its preparation and application

#816
20160376271
2016-12-29

P2X7 modulators

#817
20160376244
2016-12-29

Heterocyclic compound

#818
20160368857
2016-12-22

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

#819
20160355454
2016-12-08

Water-insoluble ruthenium catalyst composition for use in aqueous hydrogenation reactions

#820
20160354482
2016-12-08

PHARMACEUTICAL COMPOSITIONS COMPRISING MACROLIDE DIASTEREOMERS, METHODS OF THEIR SYNTHESIS AND THERAPEUTIC USES

#821
20160340704
2016-11-24

METHOD OF MAKING A BENZYLISOQUINOLINE ALKALOID (BIA) METABOLITE, ENZYMES THEREFORE

#822
20160340370
2016-11-24

Method for producing 1-indanoles and 1-indanamines

#823
20160340336
2016-11-24

Triazole agonists of the APJ receptor

#824
20160339031
2016-11-24

Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

#825
20160333039
2016-11-17

Process for the preparation of DOPO-derived compounds and compositions thereof

#826
20160332942
2016-11-17

Pharmaceutical compositions comprising monoterpenes

#827
20160332940
2016-11-17

Processes for the synthesis of chiral 1-alkanols

#828
20160326161
2016-11-10

SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

#829
20160326110
2016-11-10

Substituted 5 membered heterocyclic compounds and preparation thereof

#830
20160318893
2016-11-03

STEREO-SPECIFIC SYNTHESIS OF (13R)-MANOYL OXIDE

#831
20160318885
2016-11-03

γ-aminobutyric acid (GABA) analogues for the treatment of pain and other disorders

#832
20160318858
2016-11-03

Methods and compounds useful in the synthesis of orexin-2 receptor antagonists

#833
20160318851
2016-11-03

Process for preparing levomilnacipran

#834
20160311849
2016-10-27

Industrial process for the synthesis of ulipristal acetate and its 4′-acetyl analogue

#835
20160311757
2016-10-27

Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion

#836
20160304449
2016-10-20

Method for producing D-form or L-form amino acid derivative having thiol group

#837
20160297825
2016-10-13

Efficient method for the preparation of tofacitinib citrate

#838
20160297773
2016-10-13

Processes for the preparation of pyrimidinylcyclopentane compounds

#839
20160289166
2016-10-06

Fingolimod hydrochloride process

#840
20160280721
2016-09-29

Cross-coupling of unactivated secondary boronic acids

#841
20160280636
2016-09-29

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#842
20160280630
2016-09-29

(3R) epimer of octahydro-7,7-dimethyl-8-methylene 1H-3a, 6-methanoazulene-3-yl acetate, composition, synthesis process and use of said epimer

#843
20160279107
2016-09-29

Benzothiazolone compound

#844
20160272609
2016-09-22

Organocatalytic process for asymmetric synthesis of decanolides

#845
20160272608
2016-09-22

Organocatalytic process for asymmetric synthesis of decanolides

#846
20160272597
2016-09-22

Oxazolidinone antibacterial compound

#847
20160257671
2016-09-08

SHIP1 modulators and methods related thereto

#848
20160257640
2016-09-08

Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds

#849
20160257633
2016-09-08

Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone

#850
20160250625
2016-09-01

Method of producing optically active compound

#851
20160244428
2016-08-25

Efficient process for the preparation of Esomeprazole ()-Binol complex

#852
20160244418
2016-08-25

Derivatives of sobetirome

#853
20160244411
2016-08-25

TAU IMAGING PROBE

#854
20160237107
2016-08-18

Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridines

#855
20160237072
2016-08-18

Oxazolidinones as modulators of mGluR5

#856
20160237044
2016-08-18

SUBSTITUTED PHENYLALANINE DERIVATIVES

#857
20160237043
2016-08-18

KDM1A inhibitors for the treatment of disease

#858
20160235727
2016-08-18

Pyrrolidine derived beta 3 adrenergic receptor agonists

#859
20160229886
2016-08-11

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

#860
20160229881
2016-08-11

Methods for preparation of glycosphingolipids and uses thereof

#861
20160229838
2016-08-11

AMPK-activating heterocyclic compounds and methods for using the same

#862
20160229830
2016-08-11

Glucosylceramide synthase inhibitors for the treatment of diseases

#863
20160228443
2016-08-11

Pyrrolopyrimidine compounds and uses thereof

#864
20160228395
2016-08-11

()-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid

#865
20160222420
2016-08-04

Methods and materials for the production of monomers for nylon-4/polyester production

#866
20160207945
2016-07-21

Chiral aryl or aryl-alkyl phosphoramidate dexamphetamine precursors having a regioisomeric purity >99%

#867
20160207925
2016-07-21

L-METHYLFOLATE SALT PREPARATIONS, MEDICAMENTS, AND NUTRITIONAL SUPPLEMENTS COMPRISING SUCH SALTS THEREOF

#868
20160200665
2016-07-14

SYNTHESIS OF BIPHENYLALANINOL VIA NOVEL INTERMEDIATES

#869
20160194680
2016-07-07

Enzymatic Route For The Preparation Of Chiral Gamma-Aryl-Beta-Aminobutyric Acid Derivatives

#870
20160194272
2016-07-07

PROCESS FOR THE ETHERIFICATION OF AMINO ALCOHOLS

#871
20160185812
2016-06-30

Process for synthesizing highly optically active 1,3-disubstituted allenes

#872
20160185760
2016-06-30

PROCESS FOR THE PREPARATION OF MALIC ACID SALT OF SUNITINIB

#873
20160185734
2016-06-30

Method for producing optically active 5-hydroxy-3-ketoester

#874
20160185702
2016-06-30

Using mixtures of E/Z isomers to obtain quantitatively specific products by combining asymmetric hydrogenation and isomerization

#875
20160185685
2016-06-30

Bisphosphites having a central 2,3′-biphenol unit

#876
20160185683
2016-06-30

Process of asymmetric hydrogenation of ketals and acetals

#877
20160176881
2016-06-23

Short-acting benzodiazepine salts and their polymorphic forms

#878
20160176821
2016-06-23

L-tartrate salt of pridopidine

#879
20160176773
2016-06-23

Enantioselective synthesis of α-quaternary mannich adducts by palladium-catalyzed allylic alkylation

#880
20160168074
2016-06-16

Derivatives of 2,2,6-trimethylcyclohexane-carboxylate

#881
20160159729
2016-06-09

Method of producing optically active β-aminocarbonyl compound

#882
20160158162
2016-06-09

Pharmaceutical compositions comprising monoterpenes

#883
20160157485
2016-06-09

4-membered ring carboxamides used as nematicides

#884
20160151331
2016-06-02

Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

#885
20160145253
2016-05-26

Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors

#886
20160137645
2016-05-19

Compounds useful for producing an optically active diazabicyclooctane compound

#887
20160137588
2016-05-19

Inhibitors of cognitive decline

#888
20160136140
2016-05-19

Chemical compounds

#889
20160136111
2016-05-19

Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine

#890
20160130193
2016-05-12

PRODUCTION METHOD FOR OPTICALLY ACTIVE ALCOHOL COMPOUND

#891
20160122287
2016-05-05

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

#892
20160107983
2016-04-21

Process for the preparation of 3-aryloxy-3-phenylpropylamine and salt thereof

#893
20160102045
2016-04-14

Method for synthesizing optically active α-amino acid using chiral metal complex comprising axially chiral N-(2-acylaryl)-2-[5,7-dihydro-6H-dibenzo[c,e]azepin-6-yl] acetamide compound and amino acid

#894
20160083334
2016-03-24

Process for the preparation of arformoterol or salt thereof

#895
20160076063
2016-03-17

Method for producing (Z)-2-benzoyloxy-12-heptadecene and (2S,12Z)-2-hydroxy-12-heptadecene and method for producing (2S,12Z)-2-acetoxy-12-heptadecene

#896
20160075676
2016-03-17

Production of adipic acid and derivatives from carbohydrate-containing materials

#897
20160075670
2016-03-17

BENZOTHIAZOLONE COMPOUND

#898
20160075647
2016-03-17

Phenicol antibacterial agents

#899
20160075636
2016-03-17

Process for the Preparation of (-)-(4-Chloro-Phenyl)-(3-Trifluoromethyl-Phenoxy)-Acetic Acid 2-Acetylamino-Ethyl Ester

#900
20160075634
2016-03-17

Methods for the synthesis of sphingomyelins and dihydrosphingomyelins